Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors

NCT00618735 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: BIIB021
DRUG: BIIB021

Sponsor

Biogen